Related Experiment Video
Updated: Jul 20, 2026

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin
1Laboratory for Shock and Trauma Research, Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion, 31096 Haifa, Israel. hirsh@tx.technion.ac.il
Abstract:
Lysosomal processing of lethal toxin (LTX) is a key event in the pathogenesis of anthrax. This study investigated the ability of chloroquine (CQ) to interfere with this processing and thereby to reduce suppression of T lymphocytes. T lymphocytes isolated from blood were activated, by cross-linking of CD3, in both the absence and presence of LTX and CQ and then were assayed by flow cytometry and immunoblotting. LTX was found to disrupt intracellular signaling, and it down-regulated T lymphocyte function. CQ significantly reduced the harmful effects of LTX and protected the activation and cytokine production of T lymphocytes. This effect may indicate a promising strategy in the treatment of anthrax.
More Related Videos
Related Concept Videos
Inhalation Anthrax
Antiprotozoal Agents
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Diphtheria
Botulism

